These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5316913)

  • 41. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analysis of factors which affect the measurement of factor VIII inhibitor by Bethesda method].
    Takahashi Y; Arai M; Fukutake K
    Rinsho Byori; 1996 May; 44(5):449-55. PubMed ID: 8676565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A collaborative study designed to establish the 4th International Standard for Heparin.
    Thomas DP; Curtis AD; Barrowcliffe TW
    Thromb Haemost; 1984 Oct; 52(2):148-53. PubMed ID: 6523431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Freeze-dried activated substrate for factor VIII assays.
    Margolis J
    Dev Biol Stand; 1987; 67():163-7. PubMed ID: 3111909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.
    Ferguson M; Walker D; Cohen B
    Biologicals; 1997 Sep; 25(3):283-8. PubMed ID: 9324996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of the Bethesda and New Oxford methods of factor VIII antibody assay.
    Austen DE; Lechner K; Rizza CR; Rhymes IL
    Thromb Haemost; 1982 Feb; 47(1):72-5. PubMed ID: 6803384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of substrate and diluent for factor VIII activity in highly purified factor VIII concentrate and patient plasma infused factor VIII concentrate].
    Takahashi I; Furuta M; Mizuno S; Takamatsu J; Kamiya T
    Rinsho Byori; 1993 Jul; 41(7):825-30. PubMed ID: 8361054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The stability of factor VIII in heparinized plasma.
    Krachmalnicoff A; Thomas DP
    Thromb Haemost; 1983 Jun; 49(3):224-7. PubMed ID: 6410534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cap survey results for factor VIII assays (1977-1978).
    Kocoshis TA; Triplett DA
    Am J Clin Pathol; 1979 Aug; 72(2 Suppl):346-51. PubMed ID: 474513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
    Sultan Y; Loyer F
    J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Standards for assay of von Willebrand factor concentrates: a collaborative study.
    Fricke WA; Lamb MA; Rastogi SC
    Thromb Haemost; 1993 Aug; 70(2):351-6. PubMed ID: 8236147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The recovery of factor VIII from fresh-frozen indated and outdated human plasma.
    Whitman DE; Switzer ME; McKee PA
    Thromb Haemost; 1976 Aug; 36(1):71-7. PubMed ID: 1036829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An international collaborative study to replace the 1st international standard for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standardization of factor VIII: establishment and use of secondary standards.
    Panicucci F; Angeloni G; Arrighi S; Bucci E; DiMambro G; Lecchini L; Pitruzzello S; Positano M
    J Biol Stand; 1985 Apr; 13(2):115-21. PubMed ID: 3922990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Approaches to the measurement of the in vivo response to factor VIII concentrate infusion.
    Ofosu FA; Blajchman MA; Barr R; Inwood M
    Thromb Res; 1985 Aug; 39(4):429-37. PubMed ID: 3931292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of phospholipids on the assessment of factor VIII activity.
    Mikaelsson M; Oswaldsson U; Sandberg H
    Haemophilia; 1998 Jul; 4(4):646-50. PubMed ID: 9873808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assay of AHF concentrates and standards: failure to eliminate variability with a monographed assay.
    Heldebrant C; Kleszynski R; Short M; Aronson D; Brown L; Jacoby G; Lee M; Thomas D; Barrowcliffe T; Howell I; Johnson RC
    Thromb Res; 1983 May; 30(4):337-46. PubMed ID: 6412386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A collaborative study on the suitability of commercial, assayed plasmas for one-stage factor VIII assays.
    Harper TA; Chauhan K
    Am J Clin Pathol; 1982 May; 77(5):614-8. PubMed ID: 6805309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability of "standard" plasmas used by clinical laboratories for one-stage factor VIII assays.
    Harper TA; Bailey EL; Chauhan K
    Am J Clin Pathol; 1981 Feb; 75(2):197-200. PubMed ID: 6781330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.